RxDoctor Payments Data

Stacy Trinkle, MD

Family Medicine · Louisville, KYNPI 1114982683

Payments from drug & device makers

$1,635in general payments, 2019–2025

Across 131 payments — averaging $12.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$416
  • Lilly USA, LLC$153
  • Pfizer$145
  • Astellas Pharma US Inc$131
  • Johnson & Johnson$130
  • Amgen$109
  • plus $550 from 13 others

What the payments were for

  • Food & beverage$1,635100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,635 in reported general payments places this provider in the 65th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$108,968
Medicare patients
213
Services billed
1,143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin95$111,969
EliquisApixaban129$109,615
OzempicSemaglutide67$64,646
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$46,510
MyrbetriqMirabegron26$28,527
JanuviaSitagliptin Phosphate20$27,847
XareltoRivaroxaban21$23,240
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$19,824
VascepaIcosapent Ethyl21$11,456
Sumatriptan Succinate46$11,115
SymbicortBudesonide/Formoterol Fumarate31$9,787
PremarinEstrogens, Conjugated18$9,470
Lantus SolostarInsulin Glargine,hum.Rec.Anlog38$8,010
NexletolBempedoic Acid18$7,149
Levothyroxine Sodium493$5,361

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$145$119,085147 claims
Novo NordiskOzempic$416$64,64667 claims
GSKTrelegy Ellipta$94$46,51055 claims
Astellas Pharma US IncMyrbetriq$131$28,52726 claims
MerckJanuvia$12$27,84720 claims
Johnson & JohnsonXarelto$130$23,24021 claims
AstraZenecaSymbicort$52$9,78731 claims
AbbVieSynthroid$93$1,68956 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →